000 | 01928 a2200529 4500 | ||
---|---|---|---|
005 | 20250517205919.0 | ||
264 | 0 | _c20190924 | |
008 | 201909s 0 0 eng d | ||
022 | _a2040-2058 | ||
024 | 7 |
_a10.3851/IMP3231 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBeesetti, Hemalatha | |
245 | 0 | 0 |
_aA quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells. _h[electronic resource] |
260 |
_bAntiviral therapy _c2018 |
||
300 |
_a385-394 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigens, Viral _ximmunology |
650 | 0 | 4 |
_aAntiviral Agents _xchemical synthesis |
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 | _aChlorocebus aethiops |
650 | 0 | 4 |
_aDengue Virus _xdrug effects |
650 | 0 | 4 | _aHigh-Throughput Screening Assays |
650 | 0 | 4 | _aMolecular Docking Simulation |
650 | 0 | 4 |
_aProtease Inhibitors _xchemical synthesis |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 | _aProtein Interaction Domains and Motifs |
650 | 0 | 4 | _aProtein Structure, Secondary |
650 | 0 | 4 |
_aQuinolines _xchemical synthesis |
650 | 0 | 4 |
_aRNA Helicases _xantagonists & inhibitors |
650 | 0 | 4 |
_aRNA, Viral _xantagonists & inhibitors |
650 | 0 | 4 |
_aRecombinant Proteins _xgenetics |
650 | 0 | 4 |
_aSerine Endopeptidases _xgenetics |
650 | 0 | 4 | _aSerogroup |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 | _aVero Cells |
650 | 0 | 4 |
_aViral Nonstructural Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aVirus Replication _xdrug effects |
700 | 1 | _aTyagi, Poornima | |
700 | 1 | _aMedapi, Brahmam | |
700 | 1 | _aKrishna, Vagolu Siva | |
700 | 1 | _aSriram, Dharmarajan | |
700 | 1 | _aKhanna, Navin | |
700 | 1 | _aSwaminathan, Sathyamangalam | |
773 | 0 |
_tAntiviral therapy _gvol. 23 _gno. 5 _gp. 385-394 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3851/IMP3231 _zAvailable from publisher's website |
999 |
_c28221958 _d28221958 |